4D pharma is a world leader in the development of Live Biotherapeutics, emerging class of drugs, defined by FDA as biological products that have live organism, such as a bacterium, that is the prevention, treatment or cure of a disease.
Industry: | Health Care |
Sector: | Health Care |
Website: | www.4dpharmaplc.com |
Twitter: | @4dpharmaplc |
Exchange: | LSE |
Admission date: | 18 Feb 2014 |
Market: | Aim |
Region: | Europe |
1 Apr 2022 | Final Results |
12 Nov 2022 | Annual Meeting |
8 Nov 2022 | Annual Meeting |
23 Mar 2022 | Conference Call |